Thus, Fra-2-overexpressing BC cells show a higher capability to adhere to ECM components, to interact with glycoproteins on the vascular endothelial surface and to form metastases in xenograft mouse models [51, 53]. This evidence concerns the gene FOSL2 and breast cancer.